Shop 0300 111 4000
View cart
Donate

Helpline

0300 111 4000
View cart

Search

Search results

Resources

From our newsletters to the recordings of our webinars and everything in-between, use the filters (below) to find the content that's right for you.

Light sensing small molecule given green light

Biotechnology company Kiora Pharmaceuticals has been given the go-ahead to start in-human testing of a novel “small molecule” treatment, known as KIO-301, for advanced vision loss in retinitis pigmentosa (RP). The phase 1b clinical trial will take place in Adelaide, Australia, and will begin enrolling participants towards the end of 2022.

The cover of Look Forward Summer 2024 (issue 183) featuring a group of eight people looking down at the camera with blue sky above them

Look Forward – Summer 2024 – Issue 183

This edition includes exciting news about our Annual and Professionals’ Conferences. We hope as many of you as possible can join us in Manchester, or online, in September. You’ll also find updates about the latest research and a feature on one of our funded researchers, Dr Jörn Lakowski.

Eppendorf tubes in rack

Research round-up, spring 2023

Progress towards treatments for inherited retinal conditions continues to gather pace and there’s been lots going on in the last few months, with more and more approaches being explored. This round-up gives a flavour of the variety of developments, including plenty that are not specific to a particular genetic fault.